Literature DB >> 6833512

Impairment of neutrophil chemotaxis by serum from patients with chronic lymphoproliferative disease.

U Jayaswal, S Roper, S Roath.   

Abstract

The sera of 74 individuals with chronic lymphoproliferative disease were screened for the presence of inhibitory activity against neutrophil chemotaxis. This was present in more than half the patients with IgA myeloma and Hodgkin's disease but was less common in chronic lymphocytic leukaemia, lymphocytic lymphoma and non-IgA paraproteinaemia. Heating the sera prior to testing frequently enhanced inhibitory activity particularly in myeloma and lymphoma.

Entities:  

Mesh：

Year:  1983        PMID： 6833512      PMCID： PMC498243          DOI： 10.1136/jcp.36.4.449

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  23 in total

1.  Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections.

Authors:  D C Dale; A S Fauci; S M Wolff
Journal:  N Engl J Med       Date:  1974-11-28       Impact factor: 91.245

2.  The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanism of release.

Authors:  E L Becker; H J Showell
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

3.  Effects of tetracycline on leukotaxis.

Authors:  R R Martin; G A Warr; R B Couch; H Yeager; V Knight
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator.

Authors:  P A Ward; J L Berenberg
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

5.  An inhibitor of chemotaxis and phagocytosis in reticulum cell sarcoma.

Authors:  T Ruutu; P Ruutu; P Vuopio; K Franssila; E Linder
Journal:  Scand J Haematol       Date:  1975-08

6.  A raft technique for chemotaxis: a versatile method suitable for clinical studies.

Authors:  I E Addison; J W Babbage
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

7.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

8.  Serum chemotactic inhibitory activity: heat activation of chemotactic inhibition.

Authors:  D E Epps; R C Williams
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

9.  Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge.

Authors:  J I Gallin; J R Durocher; A P Kaplan
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

10.  IgA and IgM cytoplastic inclusions in a series of cases of chronic lymphocytic leukaemia.

Authors:  J C Cawley; J Smith; A H Goldstone; J Emmines; J Hamblin; L Hough
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330
View more
  2 in total

1.  Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia.

Authors:  Dimitrios P Kontoyiannis; Sarah P Georgiadou; William G Wierda; Susan Wright; Nathaniel D Albert; Alessandra Ferrajoli; Michael Keating; Russell E Lewis
Journal:  Leuk Lymphoma       Date:  2013-02-20

2.  An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signature.

Authors:  Zhengyu Yu; Bingquan Qiu; Linfeng Li; Jing Xu; Hui Zhou; Ting Niu
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.